Ocular Therapeutix (OCUL) FCF Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38,763.00 |
| Dec 31, 2025 | -26,381.00 |
| Sep 30, 2025 | -16,269.00 |
| Jun 30, 2025 | 53,132.00 |
| Mar 31, 2025 | 29,656.00 |
| Dec 31, 2024 | 62,073.00 |
| Sep 30, 2024 | 203,555.00 |
| Jun 30, 2024 | 295,586.00 |
| Mar 31, 2024 | 374,492.00 |
| Dec 31, 2023 | 234,514.00 |
| Sep 30, 2023 | 239,561.00 |
| Jun 30, 2023 | 167,945.00 |
| Mar 31, 2023 | 362,642.00 |
| Dec 31, 2022 | 203,454.00 |
| Sep 30, 2022 | 245,530.00 |
| Jun 30, 2022 | 236,501.00 |
| Mar 31, 2022 | 327,391.00 |
| Dec 31, 2021 | 149,446.00 |
| Sep 30, 2021 | 164,584.00 |
| Jun 30, 2021 | 206,945.00 |
| Mar 31, 2021 | 201,463.00 |
| Dec 31, 2020 | 222,667.00 |
| Sep 30, 2020 | 2.36 Mn |
| Jun 30, 2020 | 109,760.00 |
| Mar 31, 2020 | 230,688.00 |
| Dec 31, 2019 | 28,779.00 |
| Sep 30, 2019 | 212,922.00 |
| Jun 30, 2019 | 132,382.00 |
| Mar 31, 2019 | 1.20 Mn |